DAVE INC (DAVE)

US23834J2015 - Common Stock

87.84  +1.12 (+1.29%)

After market: 86.5002 -1.34 (-1.53%)

Fundamental Rating

5

DAVE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 52 industry peers in the Consumer Finance industry. No worries on liquidiy or solvency for DAVE as it has an excellent financial health rating, but there are worries on the profitability. DAVE is valued quite expensively, but it does show have an excellent growth rating.



3

1. Profitability

1.1 Basic Checks

DAVE had positive earnings in the past year.
In the past year DAVE had a positive cash flow from operations.
In the past 5 years DAVE reported 4 times negative net income.
In the past 5 years DAVE reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 15.15%, DAVE belongs to the top of the industry, outperforming 98.08% of the companies in the same industry.
DAVE has a Return On Equity of 26.47%. This is amongst the best in the industry. DAVE outperforms 90.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.18%, DAVE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA 15.15%
ROE 26.47%
ROIC 5.18%
ROA(3y)-23.39%
ROA(5y)-15.63%
ROE(3y)-76.11%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DAVE has a Profit Margin of 12.92%. This is in the better half of the industry: DAVE outperforms 65.38% of its industry peers.
DAVE's Operating Margin of 4.82% is in line compared to the rest of the industry. DAVE outperforms 46.15% of its industry peers.
Industry RankSector Rank
OM 4.82%
PM (TTM) 12.92%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

DAVE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, DAVE has more shares outstanding
The debt/assets ratio for DAVE is higher compared to a year ago.

2.2 Solvency

DAVE has an Altman-Z score of 7.22. This indicates that DAVE is financially healthy and has little risk of bankruptcy at the moment.
DAVE's Altman-Z score of 7.22 is amongst the best of the industry. DAVE outperforms 98.08% of its industry peers.
DAVE has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
The Debt to FCF ratio of DAVE (0.82) is better than 90.38% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that DAVE is not too dependend on debt financing.
DAVE has a Debt to Equity ratio of 0.48. This is in the better half of the industry: DAVE outperforms 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 0.82
Altman-Z 7.22
ROIC/WACC0.61
WACC8.47%

2.3 Liquidity

DAVE has a Current Ratio of 6.81. This indicates that DAVE is financially healthy and has no problem in meeting its short term obligations.
DAVE has a Current ratio of 6.81. This is amongst the best in the industry. DAVE outperforms 92.31% of its industry peers.
DAVE has a Quick Ratio of 6.81. This indicates that DAVE is financially healthy and has no problem in meeting its short term obligations.
DAVE's Quick ratio of 6.81 is amongst the best of the industry. DAVE outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 6.81
Quick Ratio 6.81

7

3. Growth

3.1 Past

DAVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.51%, which is quite impressive.
DAVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.00%.
The Revenue has been growing by 28.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)113.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.97%
Revenue 1Y (TTM)30%
Revenue growth 3Y28.61%
Revenue growth 5YN/A
Sales Q2Q%40.56%

3.2 Future

The Earnings Per Share is expected to grow by 31.87% on average over the next years. This is a very strong growth
Based on estimates for the next years, DAVE will show a quite strong growth in Revenue. The Revenue will grow by 17.54% on average per year.
EPS Next Y206.21%
EPS Next 2Y65.37%
EPS Next 3Y50.74%
EPS Next 5Y31.87%
Revenue Next Year37.69%
Revenue Next 2Y28.29%
Revenue Next 3Y24.77%
Revenue Next 5Y17.54%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 135.14, which means the current valuation is very expensive for DAVE.
Based on the Price/Earnings ratio, DAVE is valued a bit more expensive than 75.00% of the companies in the same industry.
DAVE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.73.
DAVE is valuated quite expensively with a Price/Forward Earnings ratio of 34.26.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DAVE indicates a slightly more expensive valuation: DAVE is more expensive than 73.08% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, DAVE is valued quite expensively.
Industry RankSector Rank
PE 135.14
Fwd PE 34.26

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DAVE.
The rest of the industry has a similar Price/Free Cash Flow ratio as DAVE.
Industry RankSector Rank
P/FCF 12.28
EV/EBITDA 48.21

4.3 Compensation for Growth

DAVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DAVE's earnings are expected to grow with 50.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y65.37%
EPS Next 3Y50.74%

0

5. Dividend

5.1 Amount

DAVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DAVE INC

NASDAQ:DAVE (12/20/2024, 8:04:47 PM)

After market: 86.5002 -1.34 (-1.53%)

87.84

+1.12 (+1.29%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners47.78%
Inst Owner Change38.53%
Ins Owners16.4%
Ins Owner Change-11.03%
Market Cap1.12B
Analysts83.08
Price Target101.42 (15.46%)
Short Float %9.6%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)243.54%
Min EPS beat(2)126.26%
Max EPS beat(2)360.82%
EPS beat(4)4
Avg EPS beat(4)182.63%
Min EPS beat(4)101.43%
Max EPS beat(4)360.82%
EPS beat(8)8
Avg EPS beat(8)109.96%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.19%
Min Revenue beat(2)4.01%
Max Revenue beat(2)12.37%
Revenue beat(4)4
Avg Revenue beat(4)7.74%
Min Revenue beat(4)1.99%
Max Revenue beat(4)12.58%
Revenue beat(8)5
Avg Revenue beat(8)3.52%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)60.74%
EPS NQ rev (1m)433.78%
EPS NQ rev (3m)91.13%
EPS NY rev (1m)33.85%
EPS NY rev (3m)33.85%
Revenue NQ rev (1m)3.38%
Revenue NQ rev (3m)6.24%
Revenue NY rev (1m)6.46%
Revenue NY rev (3m)6.46%
Valuation
Industry RankSector Rank
PE 135.14
Fwd PE 34.26
P/S 3.51
P/FCF 12.28
P/OCF 11.32
P/B 7.19
P/tB 7.9
EV/EBITDA 48.21
EPS(TTM)0.65
EY0.74%
EPS(NY)2.56
Fwd EY2.92%
FCF(TTM)7.15
FCFY8.14%
OCF(TTM)7.76
OCFY8.84%
SpS25.03
BVpS12.21
TBVpS11.11
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.15%
ROE 26.47%
ROCE 6.55%
ROIC 5.18%
ROICexc 7.61%
ROICexgc 8.35%
OM 4.82%
PM (TTM) 12.92%
GM N/A
FCFM 28.59%
ROA(3y)-23.39%
ROA(5y)-15.63%
ROE(3y)-76.11%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 0.82
Debt/EBITDA 3.35
Cap/Depr 110.59%
Cap/Sales 2.43%
Interest Coverage 1.42
Cash Conversion 441.94%
Profit Quality 221.33%
Current Ratio 6.81
Quick Ratio 6.81
Altman-Z 7.22
F-Score8
WACC8.47%
ROIC/WACC0.61
Cap/Depr(3y)165.72%
Cap/Depr(5y)201.09%
Cap/Sales(3y)4.03%
Cap/Sales(5y)3.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.97%
EPS Next Y206.21%
EPS Next 2Y65.37%
EPS Next 3Y50.74%
EPS Next 5Y31.87%
Revenue 1Y (TTM)30%
Revenue growth 3Y28.61%
Revenue growth 5YN/A
Sales Q2Q%40.56%
Revenue Next Year37.69%
Revenue Next 2Y28.29%
Revenue Next 3Y24.77%
Revenue Next 5Y17.54%
EBIT growth 1Y123.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year225.48%
EBIT Next 3Y55.56%
EBIT Next 5Y38.38%
FCF growth 1Y418.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y611.13%
OCF growth 3YN/A
OCF growth 5YN/A